24 May 2013
Keywords: novartis, painkiller, prexige, cleared, eu, swiss, drug
Article | 13 November 2006
Swiss drug major Novartis' Prexige (lumiracoxib) has been approved in the European Union as a new treatment option for patients ...
Enjoying this article? To continue reading you need to login or subscribe.
Subscriptions are £60 per month, pay as you go.
Find out more details.
13 November 2006
23 May 2013
© 2013 thepharmaletter.com